Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.62 AUD | -2.12% | -5.71% | -24.88% |
Jun. 03 | Swissmedic Grants Mayne Pharma Group Expanded Kapanol Dosage Approvals in Switzerland | MT |
May. 24 | Mayne Pharma Reiterates H2 FY24 Outlook in Wake of Change Healthcare Cyberattack | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.88% | 253M | |
+20.34% | 43.46B | |
+25.20% | 22.61B | |
+16.89% | 15.15B | |
+23.55% | 14.83B | |
+57.39% | 13.08B | |
-0.05% | 6.79B | |
-12.06% | 6.72B | |
-8.87% | 5.73B | |
+12.71% | 5.45B |
- Stock Market
- Equities
- MYX Stock
- News Mayne Pharma Group Limited
- Transcript : Mayne Pharma Group Limited, 2023 Earnings Call, Aug 31, 2023